No Data
No Data
Adient Raised to Neutral From Underperform by Exane BNP Paribas
Adient Raised to Neutral From Underperform by Exane BNP Paribas
Adient Price Target Announced at $26.00/Share by Exane BNP Paribas
Adient Price Target Announced at $26.00/Share by Exane BNP Paribas
BNP Paribas Upgrades Adient to Neutral From Underperform, Raises Price Target to $26 From $24
Adient (ADNT) has an average hold rating and a price target range of $24 to $68, according to analysts polled by Capital IQ. Price: 24.98, Change: +0.27, Percent Change: +1.09
BNP Paribas Upgrades Adient(ADNT.US) to Hold Rating, Announces Target Price $26
BNP Paribas analyst James Picariello upgrades $Adient(ADNT.US)$ to a hold rating, and sets the target price at $26.According to TipRanks data, the analyst has a success rate of 67.5% and a total avera
How Is The Market Feeling About Adient?
Adient's (NYSE:ADNT) short percent of float has risen 5.8% since its last report. The company recently reported that it has 4.84 million shares sold short, which is 7.66% of all regular shares that ar
Insiders At Adient Sold US$1.4m In Stock, Alluding To Potential Weakness
Many Adient plc (NYSE:ADNT) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable